分类： health

In Taoyuan, northern Taiwan, a remarkable therapeutic revolution is unfolding at the Therapeutic Riding Center where children with neurological conditions discover profound healing through equine-assisted interventions. The center specializes in providing transformative experiences for youth diagnosed with cerebral palsy, autism spectrum disorder, ADHD, and rare genetic conditions like Angelman Syndrome.

Eighteen-year-old Chen You-ching, who received a cerebral palsy diagnosis over sixteen years ago, exemplifies the program’s success. Her father, Hector Chen, recounts how equine therapy has become an essential weekly ritual that consistently brings joy and therapeutic benefits. “The first time she mounted a horse, her happiness was undeniable,” he observed, noting the sustained positive impact through her teenage years.

The science behind animal-assisted therapy continues to gain global recognition, particularly for addressing intellectual disabilities and trauma recovery. At this Taiwanese facility, specially trained horses undergo rigorous conditioning to remain calm during unpredictable movements and multiple simultaneous interactions. These equine partners demonstrate extraordinary patience, often standing motionless for extended periods while children hug them or listen to their heartbeats.

Abigail Liu reports dramatic developmental breakthroughs in her five-year-old daughter Ayah, who has Angelman Syndrome. “She became noticeably less fearful of unfamiliar experiences and developed willingness to attempt new activities following her equine sessions,” Liu stated.

Alain Chang, a riding instructor at the Fang Hsing-Chung Social Welfare Foundation, emphasizes the unique bond forming between children and horses. “The horses display no annoyance regardless of repetitive interactions, creating a profoundly safe environment,” Chang explained. “For these children, the opportunity to touch, observe, and embrace these animals constitutes an extraordinary experiential therapy that becomes a weekly highlight they anticipate regardless of weather conditions.”

In a landmark development for global pandemic preparedness, the University of Oxford has initiated the world’s first Phase II clinical trial for a Nipah virus vaccine candidate. The trial, launched in Bangladesh—a region plagued by recurrent outbreaks—represents a critical advancement in combating one of the world’s deadliest pathogens, for which no approved vaccines or treatments currently exist.

The study involves 306 healthy adult participants aged 18-55 and is being conducted through a strategic partnership between Oxford’s Pandemic Sciences Institute, the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), and the Coalition for Epidemic Preparedness Innovations (CEPI), which is providing primary funding. The research aims to evaluate both the safety profile and immune response generated by the ChAdOx1 NipahB vaccine.

Professor Sarah Gilbert, a leading vaccinologist at Oxford, emphasized the trial’s significance: “This initiative in Bangladesh marks a pivotal advancement in our efforts to develop countermeasures against Nipah virus, a formidable health threat that continues to claim lives during periodic outbreaks.”

Professor Brian Angus, Chief Investigator at the Oxford Vaccine Group, highlighted the importance of conducting trials in affected regions: “Initiating Phase II trials in countries experiencing regular Nipah outbreaks ensures that vaccine development remains both effective and contextually relevant to those most vulnerable.”

Dr. Kent Kester, CEPI’s Executive Director of Vaccine Research, noted that Oxford’s candidate represents the most progressed vaccine initiative against the highly lethal Nipah virus, calling the trial “the culmination of years of cutting-edge research and international scientific cooperation.”

The Serum Institute of India, the world’s largest vaccine manufacturer, produced the trial vaccines in collaboration with CEPI. Dr. K Zaman, Senior Scientist at ICDDR,B and Principal Investigator in Bangladesh, emphasized that hosting this trial aligns with their two decades of Nipah surveillance and research, representing a natural progression of their scientific commitment to global health security.

Medical professionals across the United Arab Emirates are urging residents to maintain perspective regarding recent Nipah virus reports while emphasizing practical preventive measures for travelers. Contrary to widespread anxiety, physicians confirm that cancellation of travel plans remains unnecessary for most individuals.

Dr. Vinod Tahilramani, specialist at Medcare Medical Centre in Motor City, emphasizes the statistical rarity of Nipah infection: “This remains an exceptionally uncommon condition that the majority of travelers will never encounter. The general public should proceed with their scheduled itineraries without undue concern.”

Unlike highly contagious pathogens such as COVID-19 or influenza, Nipah virus demonstrates limited transmission capabilities. Infection typically requires direct exposure to bodily fluids of infected individuals or occurs within specific high-risk environments, particularly healthcare facilities during active outbreaks.

Regarding airport screening implementations in various countries, medical experts acknowledge these measures provide an additional security layer by identifying visibly ill passengers, particularly those exhibiting fever. However, physicians note the limitations of such screenings since early Nipah symptoms often mimic common viral infections.

“While screening contributes to safety protocols, it cannot guarantee complete protection,” Dr. Tahilramani notes. “This underscores the critical importance of personal awareness and prompt medical consultation when necessary.”

Travelers visiting regions with reported cases should implement straightforward precautions:
– Avoid close contact with symptomatic individuals
– Maintain rigorous hand hygiene practices
– Refrain from consuming uncovered street-vendor fruits
– Avoid raw or improperly regulated food products
– Limit non-essential hospital visits in outbreak zones
– Healthcare workers should employ full protective equipment including masks and gloves

Post-travel vigilance remains equally crucial. Dr. Deepak Dube, internal medicine specialist at International Modern Hospital Dubai, explains: “Initial presentation may resemble ordinary viral fever, but neurological symptoms including confusion, excessive drowsiness, seizures, or behavioral changes require immediate medical attention.”

Medical professionals advise that fever accompanied by confusion or seizures warrants urgent care. Affected individuals should avoid public gatherings and explicitly inform healthcare providers of recent travel history.

The consensus among UAE medical experts emphasizes informed preparedness rather than alarm. Through awareness, practical precautions, and timely medical response, travelers can mitigate risks while maintaining normal travel schedules.

After enduring fourteen years of unexplained suffering, a 27-year-old UAE expatriate has finally received validation for her chronic pain condition. Shatha’s medical journey began at age twelve when mysterious symptoms emerged—debilitating fatigue, migratory pain patterns, and non-restorative sleep that defied conventional diagnosis.

According to Dr. Sehriban Diab, Consultant Rheumatologist at Sheikh Shakhbout Medical City (SSMC), fibromyalgia represents a complex neurological disorder characterized by amplified pain signaling pathways. “Patients primarily experience muscular and connective tissue discomfort rather than joint inflammation,” Dr. Diab explained, noting accompanying symptoms including cognitive dysfunction, sleep disturbances, and gastrointestinal complications.

The diagnostic challenges are particularly acute, as fibromyalgia lacks definitive biomarker testing. Physicians must rely on clinical evaluation and exclusionary diagnostics to differentiate it from thyroid disorders, nutritional deficiencies, and other autoimmune conditions.

Shatha’s breakthrough came through SSMC’s multidisciplinary approach that addressed psychological dimensions alongside physical symptoms. Mais Jawhari, Senior Physiotherapist at SSMC, emphasized that “every fibromyalgia case presents uniquely—Shatha’s root causation was psychologically anchored in childhood trauma.”

Her personalized treatment protocol incorporated psychological support, acupuncture for anxiety and sleep regulation, and structured exercise programming. “Movement constitutes a fundamental therapeutic component,” Jawhari noted, “but requires careful calibration to avoid symptom exacerbation.”

The results proved transformative. Shatha has now embraced Muay Thai martial arts as both physical rehabilitation and psychological empowerment, recently preparing for competitive tournament participation. While occasional pain persists, she reports dramatically improved quality of life and functional capacity.

Medical professionals stress that despite diagnostic delays averaging 1-2 years, comprehensive care can achieve 70-80% symptom control. Jawhari challenges the term “chronic” as potentially limiting: “The diagnosis remains, but ongoing suffering doesn’t have to.”

The World Health Organization (WHO) has issued a risk assessment following India’s confirmation of two Nipah virus cases, determining the international transmission threat remains low. In an official statement released Friday, the global health body confirmed it does not advise implementing travel restrictions or trade limitations against India despite the recent infections.

Nipah virus represents a zoonotic pathogen capable of transmission through multiple pathways: direct animal-to-human contact, consumption of contaminated food products, or human-to-human exposure. First identified during a 1998 outbreak among Malaysian pig farmers, the virus subsequently appeared in Singapore (1999) before emerging in India and Bangladesh approximately two years later. The Philippines documented cases in 2014, though Southeast Asia has remained outbreak-free in recent years. Conversely, Bangladesh has experienced near-annual outbreaks since 2001, while India continues reporting periodic cases, particularly in Kerala and West Bengal.

Fruit bats from the Pteropodidae family serve as the virus’s natural reservoir, exhibiting asymptomatic carriage while contaminating fruits consumed by intermediate hosts including pigs, horses, and domestic animals. Human infection typically presents with non-specific influenza-like symptoms: fever, headache, respiratory distress, and generalized confusion. The disease frequently progresses to severe neurological complications including encephalitis (brain inflammation) and meningitis, with mortality rates ranging from 40-75% according to UK Health Security Agency estimates.

Survivors often experience lasting neurological sequelae such as persistent seizures and personality alterations. Rare cases demonstrate viral reactivation months or years post-recovery. Currently, no approved vaccines or antiviral treatments exist, though WHO has designated Nipah as a priority pathogen within its Research and Development Blueprint, with several candidate products undergoing development.

Healthcare providers must implement enhanced infection control protocols including patient isolation, contact/droplet precautions (medical masks, eye protection, gowns, gloves), and airborne precautions during aerosol-generating procedures. Similar protective measures are advised for animal handlers during slaughtering procedures. Early diagnosis through laboratory testing remains critical for implementing supportive care measures that can reduce mortality.

The World Health Organization (WHO) issued a reassuring assessment on Friday, January 30th, 2026, stating that the risk of international spread of the Nipah virus from India remains low. This evaluation comes after the South Asian nation confirmed two isolated cases of the infection.

In an official statement, the global health body clarified that it does not advise the implementation of any travel restrictions or trade barriers concerning India. This position underscores a confidence in existing containment measures and reflects a data-driven assessment of the outbreak’s scale.

Nipah virus is a zoonotic pathogen, transmitted initially from animals to humans, often through contaminated food or direct contact. It can lead to severe respiratory illness and encephalitis, with a high fatality rate. Past outbreaks in other parts of Asia have raised significant public health concerns, prompting swift international response.

The WHO’s calm and measured response aims to balance vigilant monitoring with the avoidance of unnecessary alarm and economic disruption. The organization typically recommends standard precautions for travelers to affected regions, emphasizing hygiene practices and avoiding contact with sick animals or consumption of raw date palm sap, a known transmission route.